Published in Ophthalmic Res on December 05, 2015
One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement. Clin Ophthalmol (2016) 0.81
Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2016) 0.76
Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis. Clin Ophthalmol (2017) 0.75
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab. Clin Ophthalmol (2017) 0.75
The epidemiology of age-related macular degeneration. Am J Ophthalmol (2004) 5.86
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology (2010) 4.65
Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology (2006) 2.72
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol (2012) 2.42
Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol (2004) 1.86
Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. J Infect Dis (2010) 1.63
Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study. Ophthalmology (2007) 1.51
The reading of components of diabetic retinopathy: an evolutionary approach for filtering normal digital fundus imaging in screening and population based studies. PLoS One (2013) 1.49
Macular telangiectasia type 2. Prog Retin Eye Res (2012) 1.44
The prevalence of type 2 idiopathic macular telangiectasia in two African populations. Ophthalmic Epidemiol (2012) 1.41
Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol (2005) 1.30
The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project. Invest Ophthalmol Vis Sci (2008) 1.25
Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiol (2010) 1.14
"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci (2012) 1.13
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12
Familial asymptomatic macular telangiectasia type 2. Ophthalmology (2009) 1.12
Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILP contributing to inhibition of phagosome maturation. J Leukoc Biol (2007) 1.11
Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology (2009) 1.11
Crowdsourcing as a novel technique for retinal fundus photography classification: analysis of images in the EPIC Norfolk cohort on behalf of the UK Biobank Eye and Vision Consortium. PLoS One (2013) 1.09
The prevalence of age-related maculopathy in iceland: Reykjavik eye study. Arch Ophthalmol (2003) 1.06
Metamorphopsia after successful retinal detachment surgery: an optical coherence tomography study. Acta Ophthalmol Scand (2005) 1.03
Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology (2013) 1.01
The Nakuru eye disease cohort study: methodology & rationale. BMC Ophthalmol (2014) 0.99
Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. Ophthalmology (2011) 0.97
Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med (2006) 0.96
Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia. Arch Ophthalmol (2008) 0.96
Structural and functional changes over time in MacTel patients. Retina (2009) 0.94
Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health (2014) 0.93
Identifying recombination hot spots in the HIV-1 genome. J Virol (2013) 0.93
Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.93
The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci (2012) 0.92
The Tromsø Eye Study: study design, methodology and results on visual acuity and refractive errors. Acta Ophthalmol (2012) 0.92
Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study. Ophthalmology (2012) 0.92
A smartphone based ophthalmoscope. Conf Proc IEEE Eng Med Biol Soc (2014) 0.90
Correction of visual impairment by cataract surgery and improved survival in older persons: the Blue Mountains Eye Study cohort. Ophthalmology (2013) 0.90
Autofluorescence imaging of choroidal neovascularization due to age-related macular degeneration. Arch Ophthalmol (2005) 0.89
Tromsø eye study: prevalence and risk factors of diabetic retinopathy. Acta Ophthalmol (2012) 0.88
Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. Ophthalmic Epidemiol (2014) 0.88
What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration? Ophthalmology (2004) 0.88
Mineralization of paraoxon and its use as a sole C and P source by a rationally designed catabolic pathway in Pseudomonas putida. Appl Environ Microbiol (2006) 0.88
Incidence and progression of epiretinal membranes in eyes after cataract surgery. Am J Ophthalmol (2013) 0.88
5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology (2005) 0.88
Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina (2015) 0.87
Measurement of normal optic nerve head parameters. Surv Ophthalmol (2012) 0.87
Incidence and progression of geographic atrophy: observations from a population-based cohort. Ophthalmology (2013) 0.87
An allometric relationship between the genome length and virion volume of viruses. J Virol (2014) 0.86
Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. Clin Experiment Ophthalmol (2010) 0.86
The interaction of indocyanine green with human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2005) 0.86
Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes. Graefes Arch Clin Exp Ophthalmol (2014) 0.86
Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta Ophthalmol (2008) 0.86
Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration. Acta Ophthalmol (2014) 0.85
Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br J Ophthalmol (2012) 0.85
Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland. The Greenland Inuit Eye Study. Ophthalmology (2008) 0.85
Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Invest Ophthalmol Vis Sci (2008) 0.85
Prevalence and correlates of diabetic retinopathy in a population-based survey of older people in Nakuru, Kenya. Ophthalmic Epidemiol (2014) 0.85
Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5). Br J Ophthalmol (2013) 0.85
Retinal crystals in type 2 idiopathic macular telangiectasia. Ophthalmology (2011) 0.85
Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR. J Cardiovasc Magn Reson (2010) 0.84
Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV? PLoS One (2012) 0.84
Localizing Microaneurysms in Fundus Images Through Singular Spectrum Analysis. IEEE Trans Biomed Eng (2016) 0.84
Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø Study. Acta Ophthalmol (2014) 0.83
The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD). Graefes Arch Clin Exp Ophthalmol (2010) 0.83
Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol (2007) 0.83
Visual outcomes 12 months after phacoemulsification cataract surgery in patients with diabetes. Acta Ophthalmol (2010) 0.82
Analysis of candidate genes for macular telangiectasia type 2. Mol Vis (2010) 0.82
Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3. Ophthalmic Epidemiol (2013) 0.82
Implications and outcome of permanent coronary sinus lead extraction and reimplantation. J Cardiovasc Electrophysiol (2005) 0.82
Long-term outcomes of phacoemulsification cataract surgery performed by trainees and consultants in an Australian cohort. Clin Experiment Ophthalmol (2012) 0.82
Relationship between retinal structures and retinal vessel caliber in normal adolescents. Invest Ophthalmol Vis Sci (2009) 0.82
Estimating the in-vivo HIV template switching and recombination rate. AIDS (2016) 0.82
Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2. Ophthalmologica (2013) 0.81
Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. Invest Ophthalmol Vis Sci (2009) 0.81
Anti-retinal antibodies in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci (2013) 0.81
In vitro study of the effects of lens extract on rat retinal neuron survival and neurite outgrowth. Ophthalmic Res (2009) 0.81
Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4). PLoS One (2013) 0.81
Retinal vascular fractals predict long-term microvascular complications in type 1 diabetes mellitus: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). Diabetologia (2014) 0.81
Infarct density distribution by MRI in the porcine model of acute and chronic myocardial infarction as a potential method transferable to the clinic. Int J Cardiovasc Imaging (2014) 0.81
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes. Ophthalmology (2009) 0.80
Tear fluid proteomics multimarkers for diabetic retinopathy screening. BMC Ophthalmol (2013) 0.80
The International Classification system and the progression of age-related macular degeneration. Curr Eye Res (2009) 0.80
Nigeria normative data for defining glaucoma in prevalence surveys. Ophthalmic Epidemiol (2015) 0.80
Identification of a potential susceptibility locus for macular telangiectasia type 2. PLoS One (2012) 0.80
Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. PLoS Med (2013) 0.79
Assessment of candidate ocular biomarkers of ageing in a South African adult population: relationship with chronological age and systemic biomarkers. Mech Ageing Dev (2013) 0.79
Basement membrane changes in capillaries of the ageing human retina. Br J Ophthalmol (2011) 0.79
The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetol (2013) 0.78
The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol (2011) 0.78
Lactation, female hormones and age-related macular degeneration: the Tromsø Study. Br J Ophthalmol (2013) 0.78
Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Ophthalmic Res (2016) 0.78
Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel project report number 5. Retina (2014) 0.78
PREVALENCE AND ASSOCIATIONS OF MYELINATED RETINAL NERVE FIBERS: Results From the Population-Based Gutenberg Health Study. Retina (2016) 0.77
Effects of fenofibric acid on diabetic macular edema: the MacuFen study. Ophthalmic Epidemiol (2014) 0.77
Combined grading for choroidal neovascularisation: colour, fluorescein angiography and autofluorescence images. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Intravitreal injection of triamcinolone acetonide for immune recovery uveitis. Retina (2006) 0.76